Research Library
EARLY TRANSLATIONAL

GHRP-2

Also known as: Pralmorelin, KP-102

Growth Factor ResearchPeptide Signaling
ClassificationSynthetic hexapeptide growth-hormone-releasing peptide and ghrelin-receptor agonist.
TargetsGHS-R1a receptor biology; Neuroendocrine signaling models

Molecular Overview

GHRP-2 (pralmorelin) is a hexapeptide secretagogue with a substantial research literature; it has been used clinically in Japan as a diagnostic agent.

Mechanistic Background

Agonism of the ghrelin/GHS receptor axis in experimental and diagnostic contexts.

What Researchers Study

Published diagnostic-use data and extensive secretagogue-pathway research.

Evidence Landscape

Current evidence level: EARLY TRANSLATIONAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Not an approved therapeutic in most jurisdictions; research material is for laboratory use only.

Documentation

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.